{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:47:22Z","timestamp":1761176842401,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.tracli.2013.06.001","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T11:02:43Z","timestamp":1375182163000},"page":"398-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15 years"],"prefix":"10.1016","volume":"20","author":[{"given":"M.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-H.","family":"Trouvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2013.06.001_bib0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.tracli.2013.06.001_bib0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0092-8674(85)90333-2","article-title":"A cellular gene encodes scrapie PrP 27-30 protein","volume":"40","author":"Oesch","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.tracli.2013.06.001_bib0015","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2013.06.001_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(98)12075-5","article-title":"Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples","volume":"353","author":"Hill","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2013.06.001_bib0025","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1537-2995.1998.38998408999.x","article-title":"The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy","volume":"38","author":"Brown","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.06.001_bib0030","first-page":"684","article-title":"A study network of human spongiform encephalopathies: 1st results","volume":"150","author":"Brandel","year":"1994","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.tracli.2013.06.001_bib0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","article-title":"Iatrogenic creutzfeldt-jakob disease, final assessment","volume":"18","author":"Brown","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tracli.2013.06.001_bib0040","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(00)02719-7","article-title":"Transmission of BSE by blood transfusion in sheep","volume":"356","author":"Houston","year":"2000","journal-title":"Lancet"},{"year":"2000","series-title":"Analyse du risque de transmission de la nouvelle variante de la maladie de Creutzfeldt-Jakob par le sang et ses d\u00e9riv\u00e9s\u00a0\u2013\u00a0Recommandations\u00a0\u2013\u00a0D\u00e9cembre","author":"Afssaps","key":"10.1016\/j.tracli.2013.06.001_bib0045"},{"year":"2000","series-title":"Revision of measures to minimising the risk of TSE transmission via blood products","author":"Afssaps","key":"10.1016\/j.tracli.2013.06.001_bib0050"},{"key":"10.1016\/j.tracli.2013.06.001_bib0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/35020688","article-title":"Predicted vCJD mortality in Great Britain","volume":"406","author":"Ghani","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tracli.2013.06.001_bib0060","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.0041-1132.2003.00586.x","article-title":"Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy","volume":"43","author":"Cervenakova","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.06.001_bib0065","series-title":"Decontamination of prions","first-page":"167","article-title":"Plasma-derived products and the challenges in the spiking materials and validation studies","author":"Flan","year":"2012"},{"year":"2004","series-title":"Analyse du risque de transmission de la variante de la maladie de Creutzfeldt-Jakob par les produits de sant\u00e9 et par les tissus et fluides d\u2019origine humaine - Actualisation des donn\u00e9es du rapport du groupe ad hoc de d\u00e9cembre 2000\u00a0\u2013\u00a0F\u00e9vrier","author":"Afssaps","key":"10.1016\/j.tracli.2013.06.001_bib0070"},{"key":"10.1016\/j.tracli.2013.06.001_bib0075","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1066838","article-title":"Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom","volume":"294","author":"Valleron","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tracli.2013.06.001_bib0080","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/ije\/dyg276","article-title":"Commentary: predicting the unpredictable: the future incidence of variant Creutzfeldt-Jakob disease","volume":"32","author":"Ghani","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.tracli.2013.06.001_bib0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ije\/dyh374","article-title":"Risk of variant Creutzfeldt-Jakob disease in France","volume":"34","author":"Chadeau-Hyam","year":"2005","journal-title":"Int J Epidemiol"},{"year":"2007","author":"Afssaps","key":"10.1016\/j.tracli.2013.06.001_bib0090"},{"year":"2009","series-title":"analyse du risque de transmission de la variante de la Maladie de Creutzfeldt-Jakob (vMCJ) par les produits de sant\u00e9 d\u2019origine humaine\u00a0\u2013\u00a0Septi\u00e8me actualisation des travaux du groupe d\u2019experts pluridisciplinaire\u00a0\u2013\u00a0Rapport de juillet","author":"Afssaps","key":"10.1016\/j.tracli.2013.06.001_bib0095"},{"key":"10.1016\/j.tracli.2013.06.001_bib0100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/path.1580","article-title":"Prevalence of lymphoreticular prion protein accumulation in UK tissue samples","volume":"203","author":"Hilton","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.tracli.2013.06.001_bib0105","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bmj.b1442","article-title":"Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross-sectional opportunistic survey","volume":"338","author":"Clewley","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.tracli.2013.06.001_bib0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1423-0410.2009.01222.x","article-title":"A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions","volume":"97","author":"Gillies","year":"2009","journal-title":"Vox Sang"},{"year":"2011","series-title":"Blood-borne transmission of vCJD re-examination of scenarios","author":"Bennett","key":"10.1016\/j.tracli.2013.06.001_bib0115"},{"key":"10.1016\/j.tracli.2013.06.001_bib0120","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2516.2009.02181.x","article-title":"Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia","author":"Peden","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.tracli.2013.06.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2516.2011.02508.x","article-title":"The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products","author":"Zaman","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.tracli.2013.06.001_bib0130","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1111\/j.1537-2995.2011.03199.x","article-title":"Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood","volume":"51","author":"Gregori","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.06.001_bib0135","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/JVI.06532-11","article-title":"Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models","volume":"86","author":"Lacroux","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.tracli.2013.06.001_bib0140","doi-asserted-by":"crossref","first-page":"pe23169","DOI":"10.1371\/journal.pone.0023169","article-title":"All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD","volume":"6","author":"McCutcheon","year":"2011","journal-title":"PLoS One"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782013004825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782013004825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:34:22Z","timestamp":1761129262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782013004825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1246782013004825"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2013.06.001","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of transmission of Creutzfeldt-Jakob disease via blood and blood products. The French risk-analysis over the last 15years","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2013.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}